Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Osteoporosis International

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01622195PMID 7696830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.

  1992cited by this paper
• Low-Dosage Micronized 17β-Estradiol Prevents Bone Loss in Postmenopausal Women

  1992cited by this paper
• Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women.

  1992cited by this paper
• Low-dosage micronized 17ß-estradiol prevents bone loss inpostmenopausal women

  1992cited by this paper
• Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.

  1992cited by this paper
• An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry

  1992cited by this paper
• Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause.

  1991cited by this paper
• Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

  1990cited by this paper
• Transdermal administration of oestrogen/progestagen hormone replacement therapy.

  1990cited by this paper
• Estrogen treatment of patients with established postmenopausal osteoporosis

  1990cited by this paper
• Osteoporosis, falls, and age in fracture of the proximal femur.

  1987cited by this paper
• Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

  1987cited by this paper
• The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss.

  1987cited by this paper
• Physical activity assessment methodology in the Five-City Project.

  1985cited by this paper
• The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss

  1984cited by this paper
• Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

  1982cited by this paper
• Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

  1982cited by this paper
• Postmenopausal osteoporosis.

  1982cited by this paper
• Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

  1979cited by this paper
• POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS: A Case-control Study

  1979cited by this paper
• LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN

  1976cited by this paper
• Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

  1976cited by this paper
• HEPATITIS B NOT TRANSMISSIBLE VIA FÆCAL-ORAL ROUTE

  1975cited by this paper
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females

  1971cited by this paper

• Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy

  2023cites this paper
• The role of menopausal hormone therapy in the prevention and treatment of low bone density in perimenopausal and postmenopausal women

  2023cites this paper
• Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

  2022cites this paper
• [Menopause, menopause hormone therapy and osteoporosis. CNGOF and GEMVi clinical practice guidelines].

  2021cites this paper
• Menopausal hormone therapy for the management of osteoporosis.

  2021cites this paper
• Diagnosis, Screening and Treatment of Osteoporosis –A Review

  2021cites this paper
• The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.

  2020cites this paper
• Alternatives to hormone replacement therapy: what is the role of calcium and vitamin D?

  2020cites this paper
• Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges

  2020cites this paper
• Bone Health in Patients With Liver Diseases.

  2020cites this paper
• CEG_A_204638 17..24

  2020cites this paper
• Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density

  2019cites this paper
• Osteoporosis in primary biliary cholangitis

  2018cites this paper
• The use of estradiol metered-dose transdermal spray in clinical practice

  2018cites this paper
• A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health.

  2017cites this paper
• Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease

  2016cites this paper
• The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

  2014cites this paper
• Is It Safe to Prevent and Treat Postmenopausal Osteoporosis

  2014cites this paper
• Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.

  2013cites this paper
• The Role of Hormone Replacement Therapy (HRT) and Tibolone in the Prevention and Treatment of Postmenopausal Osteoporosis

  2012cites this paper
• Are All Estrogens Created Equal? A Review of Oral vs. Transdermal Therapy

  2012cites this paper
• Intracapsular Hip Fractures

  2011cites this paper
• Raloxifene: Mechanism of Action, Effects on Bone Tissue, and Applicability in Clinical Traumatology Practice

  2009cites this paper
• Interventions for Osteoporosis

  2007cites this paper
• Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women

  2006cites this paper
• Clinical trials with retinoids for breast cancer chemoprevention.

  2006cites this paper
• [Osteoporosis and hormone replacement therapy].

  2005cites this paper
• Hormone replacement therapy in the prevention and treatment of osteoporosis

  2005cites this paper
• Late prevention of hip fractures with hormone replacement therapy

  2005influential citation
• Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy

  2005cites this paper
• Gonadal hormones

  2005cites this paper
• Ostéoporose et traitement hormonal substitutif

  2005cites this paper
• An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

  2004cites this paper
• The Effects of Age, Disease, Procedures, and Drugs on Bone Density

  2004cites this paper
• Breast Cancer Prevention Trials Using Retinoids

  2004cites this paper
• A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers

  2004cites this paper
• Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study.

  2003cites this paper
• Five-year changes in bone density, and their relationship to plasma estradiol and pretreatment bone density, in an older population of postmenopausal women using long-term estradiol implants

  2003cites this paper
• Atlas of Osteoporosis

  2003cites this paper
• [Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy].

  2003cites this paper
• Disease Modification in Migraine: A Concept That Has Come of Age?

  2003cites this paper
• Observance du traitement hormonal substitutif de la ménopause : résultats d’une étude prospective française de deux ans, comparant un traitement transdermique et une association fixe par voie orale

  2003cites this paper
• The Facts of Hormone Therapy for Menopausal Women

  2003cites this paper
• Compliance with oral HRT in postmenopausal women in clinical trials--meta analysis.

  2003cites this paper
• Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women

  2002cites this paper
• Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well‐preserved liver function

  2002cites this paper
• Effects of Transdermal Estradiol Delivered by a Matrix Patch on Bone Density in Hysterectomized, Postmenopausal Women: A 2-year Placebo-Controlled Trial

  2002cites this paper
• Low-dose hormone replacement therapy: effects on bone

  2002cites this paper
• Autosomal dominant retinal degeneration and bone loss in patients with a 12-bp deletion in the CRX gene.

  2001cites this paper
• Design and Conduct of Clinical Trials in Hormone Replacement Therapy

  2001cites this paper
• Estradiol and Norgestimate

  2001cites this paper
• Targeting of hormone replacement therapy immediately after menopause.

  2001cites this paper
• The Prevention of Osteoporosis Using Sequential Low-Dose Hormone Replacement Therapy with Estradiol-17β and Dydrogesterone

  2001cites this paper
• Anabolic Effect of Long-term Estrogen Replacement on Bone Collagen in Elderly Postmenopausal Women with Osteoporosis

  2001cites this paper
• Hormone Replacement Therapy and Fractures in Older Adults

  2001cites this paper
• HRT in the third millennium.

  2001cites this paper
• Drug treatment effects on disease progression.

  2001cites this paper
• Discrimination of changes in osteoporosis outcomes.

  2001cites this paper
• Vaginal Bleeding in Postmenopausal Women Taking Low‐Dose Norethindrone Acetate and Ethinyl Estradiol Combinations

  2000cites this paper
• The Decrease in Serum Bone-Specific Alkaline Phosphatase Predicts Bone Mineral Density Response to Hormone Replacement Therapy in Early Postmenopausal Women

  2000cites this paper
• [Estrogens still and always?].

  2000cites this paper
• A comparison of observational studies and randomized, controlled trials.

  2000cites this paper
• Bone health and osteoporosis.

  2000cites this paper
• The role of megestrol acetate as an alternative to conventional hormone replacement therapy

  2000cites this paper
• Long-Term Cardiovascular Effects of High “Osteoprotective” Dose Levels of 17β-Estradiol in Spontaneously Hypertensive Rats

  2000cites this paper
• Efficacy and Tolerability of a Low-dose of Oesclim® (25 mcg Daily) in the Management of Symptomatic Menopausal Women: A French Open-label Study

  2000cites this paper
• Prevention of recurrent hip fracture

  2000cites this paper
• An estradiol matrix transdermal system for the prevention of postmenopausal bone loss.

  2000cites this paper
• Bone density changes during two years treatment with tibolone or conjugated estrogens and norgestrel, compared with untreated controls in postmenopausal women

  2000cites this paper
• CARCINOMA OF THE BREAST AND HORMONE REPLACEMENT THERAPY FOR OSTEOPOROSIS

  2000cites this paper
• Bone densitometry and clinical decision making.

  1999cites this paper
• Optimising delivery systems for HRT.

  1999cites this paper
• A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.

  1999cites this paper
• Influence of Current and Past Hormone Replacement Therapy on Bone Mineral Density: A Study of Discordant Postmenopausal Twins

  1999cites this paper
• Does estrogen stimulate osteoblast function in postmenopausal women?

  1999cites this paper
• Moderation of the daily dose of HRT: prevention of osteoporosis.

  1999cites this paper
• Individual Smallest Detectable Difference in Bone Mineral Density Measurements

  1999cites this paper
• Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group.

  1999cites this paper
• The effects of six months of treatment with a low‐dose of conjugated oestrogens in menopausal women

  1999cites this paper
• [Hormone replacement therapy in the prevention of osteoporosis. Evolution of therapeutic methods].

  1999cites this paper
• Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.

  1999cites this paper
• A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

  1998cites this paper
• Clinical experience with a 7-day estrogen patch: principles and practice.

  1998cites this paper
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cites this paper
• Bone mineral density and broadband ultrasound attenuation with estrogen treatment of postmenopausal women.

  1998cites this paper
• Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability

  1998cites this paper
• Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?

  1998cites this paper
• Osteoporosis prevention.

  1997cites this paper
• Transdermal estrogen therapy.

  1997cites this paper
• Estrogen therapy and osteoporosis: principles & practice.

  1997cites this paper
• The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.

  1997cites this paper
• New developments in topical estrogen therapy.

  1997cites this paper
• Bone loss in elderly women prevented by ultralow doses of parenteral 17beta-estradiol.

  1997cites this paper
• Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.

  1997cites this paper
• Evolving toward a new paradigm for prevention of osteoporosis--the time is upon us.

  1997cites this paper
• The Usefulness of Bone Turnover in Predicting the Response to Transdermal Estrogen Therapy in Postmenopausal Osteoporosis

  1997cites this paper
• Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.

  1997cites this paper
• Randomised crossover comparison of skin irritation with two transdermal oestradiol patches

  1997cites this paper
• Hormone replacement therapy.

  1997cites this paper